(Q73286323)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126237%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126237%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

C R Pound

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126237%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A W Partin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126237%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J I Epstein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126237%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P C Walsh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126237%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126237%20AND%20SRC:MED&resulttype=core&format=json

Urologic Clinics of North America

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126237%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126237%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126237%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

395-406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126237%20AND%20SRC:MED&resulttype=core&format=json

5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate Cancer

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

Correlation of pathologic findings with progression after radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

Influence of Capsular Penetration on Progression Following Radical Prostatectomy: A Study of 196 Cases with Long-Term Followup

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

High 10-year survival rate in patients with early, untreated prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

Prospective, conservative management of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

Cancer of the prostate: is there a need for aggressive treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

Prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

The Incidence and Significance of Detectable Levels of Serum Prostate Specific Antigen After Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

Expectant management of localized prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970386-4

7 January 2021

10.1016/S0094-0143(05)70386-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126237%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference